Written By: Avasi Mohanty Bollywood is widely known to be the breeding ground for Masala. Most of this “Masala” is not only limited to gossip, disputes and patch-ups, but also to several legal snags that keep hopping up due to some reason or the other. Intellectual property squabbles nevertheless are the most popular ones. Filmmakers […]
Read moreIn a big setback to the Indian Generic Drug-makers, Delhi High Court has allowed the writ petition filed by Gilead Pharmasset LLC against the Union of India for an adverse order passed against it by the Deputy Controller of Patents & Designs. The Deputy Controller had rejected Gilead’s application for failing to satisfy the criterion […]
Read moreBeing patriotic is one thing and being affectionate about something is different. But in the garb of your patriotism, you can’t just go to the extent of seeking exclusivity over your country name to distinguish your goods and services. The General Court of EU has rejected appeal of Les Marques de (the applicant that replaced […]
Read moreWritten by: Swasti Panda The recent outrage against Rajkumar Hirani’s masterpiece ‘PK’ for hurting religious sentiments was struck down as groundless by the Delhi High Court. But just before the Hirani camp could puff out the sigh of relief from its belly, it found itself knocked over by one more legal notice alleging copyright infringement […]
Read moreWritten By: Lipsa Dash The recent outrageous news about leakage of several private pictures of Jennifer Lawrence, the Oscar winning actress, popular for being the lead star in Hollywood Blockbusters like Silver Lining Playbook and The Hunger Games, on certain image sharing forums has stirred-up the hornet’s nest. Hollywood and Music celebrities have become vulnerable […]
Read moreThe Curious Case of Sorafenib tosylate, as I had put it earlier, has finally reached its climax. In an order passed on 12 December 2014, the Supreme Court of India has declined to interfere with the order passed by IPAB upholding the grant of Compulsory License to Natco Pharma for the drug ‘Nexavar’. Supreme Court’s […]
Read more